Latest news
Loading news…
Gemphire Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Northville, Michigan, United States Founded 2014 11-50 employees For Profit
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication.
Gemphire Therapeutics was acquired by MetaVia in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
8
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 23
- Active products
- 8
- Patents granted
- 8
- Trademarks
- 1
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2014
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 2
- HQ
- Northville, Michigan, United States
- Region
- Greater Detroit Area, Great Lakes, Midwestern US
- Exit date
- Dec 31, 2019
- Closed
- Jan 30, 2020
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.8
- Trend (90d)
- -5.9
1
professional contacts at Gemphire Therapeutics
Contact execs at Gemphire Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Gemphire Therapeutics
Loading news…
FAQs about Gemphire Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.